Business Context and Reporting Period
This Form 8-K filing by Stereotaxis, Inc. covers events occurring on February 22, 2017, and February 26, 2017. The report details a change in Board composition and a significant revision to the non-employee director compensation program aimed at improving cash flow.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the reporting period. The only financial data disclosed relates to director compensation adjustments:
- Prior Cash Compensation: Approximately $46,000 annually per non-employee director.
- Prior Equity Compensation: 10,000 restricted stock units (RSUs) annually.
- New Equity Compensation (FY 2017): 60,000 RSUs annually per non-employee director (paid in two tranches of 30,000).
- New Cash Compensation: $0 (program revised to equity-only).
Material Changes Versus Prior Period
- Board Composition: Duane DeSisto resigned as a director and Audit Committee member effective February 26, 2017. The Board currently has eight members with one vacancy.
- Compensation Structure: Effective February 22, 2017, the Compensation Committee eliminated cash compensation for non-employee directors, replacing it with a significantly higher equity award (increasing from 10,000 to 60,000 RSUs annually).
Guidance, Outlook, and Management Commentary
Management stated the compensation revision was made to better align the Board with shareholders and to improve the Company's cash flow. There was no disagreement between the departing director and the Company regarding operations or policies. The Board has not yet selected a replacement for Mr. DeSisto. Further details on the new compensation arrangements will be included in the 2017 Annual Meeting proxy statement.
Investor Verification Checklist
- Verify the impact of eliminating $46,000 in annual cash compensation per director on the company's immediate cash flow.
- Confirm the timeline for filling the Board vacancy left by Duane DeSisto's resignation.
- Review the upcoming 2017 Annual Meeting proxy statement for the full terms of the new RSU vesting schedule.
- Assess whether the increase in equity awards (from 10,000 to 60,000 RSUs) will result in significant dilution to existing shareholders.